US28414H1032
US28414H1032
Elanco Animal Health Incorporat
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.45B EUR | 12.29B EUR | 11.95B EUR | 11.25B EUR |
Enterprise Value | 14.96B EUR | 15.68B EUR | 15.51B EUR | 14.72B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 17.84x | -- | -- | -- |
Price to Sales | 2.28x | 2.45x | 2.44x | 3.19x |
Price to Book | 1.74x | 1.87x | 1.84x | 1.72x |
EV/Revenue | 2.98x | 3.12x | 3.17x | 4.18x |
EV/EBITDA | 14.86x | 15.27x | 15.91x | 22.89x |
Price to FCF (P/FCF) | 13.85x | 32.44x | 37.94x | 31.86x |
EV/FCF | 18.1x | 41.38x | 49.25x | 41.7x |
FCF Yield | 7.22% | 3.08% | 2.64% | 3.14% |